Cancer Drug Repurposing: Pathophysiology, Therapeutic Targeting and Translational Opportunities
Abstract
Cancer remains a major global health challenge because of its biological complexity, marked genomic instability, tumor heterogeneity, metastatic potential, and the frequent emergence of resistance to anticancer treatment. The conventional discovery and development of new medicines is lengthy, expensive, and associated with substantial attrition during clinical development. These limitations have stimulated increasing interest in drug repurposing, a strategy in which an established medicine is investigated for a new therapeutic indication. Repurposing can exploit existing pharmacokinetic, pharmacodynamic, toxicological, manufacturing, and clinical information, potentially shortening the path from laboratory investigation to clinical evaluation. The present review integrates the major biological features of cancer with therapeutic targeting and the potential role of repurposed medicines in oncology. It discusses cancer etiology and pathophysiology, genetic and epigenetic alterations, tumor heterogeneity, cancer stem cells, tumor–stroma interactions, invasion and metastasis, and the molecular basis of therapeutic resistance. Selected examples of medicines investigated for anticancer applications—including metformin, celecoxib, mesalamine, epirubicin, quinacrine, levofloxacin, 5-fluorouracil, doxorubicin, paclitaxel, and ketoconazole—are considered in the context of the original manuscript. The review also addresses repurposing opportunities involving psychiatric medicines and…
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.